Anti-Glaucoma


Dorzasopt (Eye Drops)
(Dorzolamide / Timolol)

COMPOSITION
Each ml contains dorzolamide 20 mg, timolol 54 mg.

THERAPEUTIC INDICATIONS

- Increased intraocular pressure;
- Open-angled glaucoma (including pseudoexfoliative glaucoma and other types of secondary open-angled glaucoma).

CONTRAINDICATIONS
Hypersensibility to preparation components;
- Severe renal failure (CC less than 30 ml/mins);
- Hyperhloremic acidosis;
- Sinus bradycardia;
- AV-blockade of I and II degrees;
- Expressed heart failure;
- Cardiogenic shock;
- Dystrophic processes in cornea;
- Bronchial asthma (including the history);
- Severe obstructive lung disease;
- Severe allergic inflammation of nasal mucosa;
- Children and teenagers;
- Pregnancy.

ADVERSE EFFECTS
Generally the preparation is well tolerated. Inflammation of eyelid, irritation, dryness, visual disturbances, allergic reactions are possible. Systemic adverse effects are generally less expressed and do not lead to the preparation withdrawal.

DOSAGE AND ADMINISTRATION
1 drop of the preparation is instilled into conjunctival sac of an affected eye 2 times/day. While co-administrated with other ophthalmologic products interval between instillation should be not less than 15 minutes.

PREGNANCY AND LACTATION
Administration in pregnancy is contraindicated. Breast-feeding should be stopped during the treatment with the drug.

PRECAUTIONS
Eye drops contain preserving agent benzalkonium chloride therefore individuals wearing hard contact lenses should remove them before instillation of a product and wear again not less than in 15 minutes after instillation. One should not wear soft contact lenses during treatment with the drug as preserving agent can affect the eye.

MANUFACTURED FORM
5 ml in plastic vial with dropping stopper and screw cap, supplied with guard ring. Vial in carton box with packaging leaflet.


Anti-Glaucoma


Dorzamed (Eye Drops)

Dorzasopt (Eye Drops)

Latamed (Eye Drops)

Latasopt (Eye Drops)

Normatin (Eye Drops)




 Events & Exhibitions



More...

The most likely diagnosis is:

a. traction retinal detachment
b. tigroid fundus
c. epiretinal membrane
d. thyroid-related ophthalmopathy


WOC 2014 in Tokyo, Japan
Online submission of abstracts will open on March 1, 2013. The deadline for abstract submission is July 26, 2013 at midnight in Tokyo. Submissions will be reviewed by the WOC 2014 Scientific Program Committee. Primary authors will be notified of acceptance by early October, 2013.
More..


Researchers Develop Gene Therapy That Could Correct A Common Form Of Blindness
A new gene therapy method developed by University of Florida researchers has the potential to treat a common form of blindness that strikes both youngsters and adults.
More..


Oxygen Therapy Helps Heal Chemical and Thermal Burns in the Eyes
Scientists at the Department of Ophthalmology, Ahvaz Jundishapur University of Medical Sciences, treated 24 eyes of 22 patients with acute chemical and thermal burns in their eyes.
More..


Glaucoma Causes Higher Risk of Falls Among Older Adults
Glaucoma can affect a person's downward field of view, and this seems to be causing a higher risk of falls resulting in injury among older people with the eye disease.
More..


Why Do Birds Fly into Power Lines? Is Poor Vision the Problem?
esearch suggests that collision with human structures is the largest unintended human cause of bird deaths
More..


Diabetes and Hypertension Increase Glaucoma Risk
People with diabetes and/or hypertension are more likely to develop open-angle glaucoma (OAG) as well.
More..


Be Careful Out There: Fireworks Caused 1,300 Eye Injuries in One Month in 2010
Sparklers caused about 200 U.S. eye injuries during a one-month period in 2010.
More..


High Visual Perception Ability in Autistic People Explained
It has been noticed before that autistic people are highly able to process visual information, and this may be why.
More..


Why Cold Temperatures Increase Eye Dryness
In fact, the meibum can solidify in cold temperatures and block the meibomian gland ducts
More..




Home      |      Site Map      |      Terms of Use      |      Privacy Policy

2012 World Medicine Ophthalmics. All Rights Reserved.